Literature DB >> 29237619

Performance of the 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies in clinical practice.

Alojzija Hočevar1, Ziga Rotar1, Monika Krosel1, Saša Čučnik1, Matija Tomšič1.   

Abstract

Entities:  

Keywords:  autoimmune diseases; dermatomyositis; polymyositis

Mesh:

Year:  2017        PMID: 29237619     DOI: 10.1136/annrheumdis-2017-212774

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  5 in total

1.  Comparison of the 2017 EULAR/ACR criteria with Bohan and Peter criteria for the classification of idiopathic inflammatory myopathies.

Authors:  Benzeeta Pinto; Ramya Janardana; Raghunanadan Nadig; Anita Mahadevan; Anusha S Bhatt; John Michael Raj; Vineeta Shobha
Journal:  Clin Rheumatol       Date:  2019-03-22       Impact factor: 2.980

2.  The performance of the European League Against Rheumatism/American College of Rheumatology idiopathic inflammatory myopathies classification criteria in an expert-defined 10 year incident cohort.

Authors:  Matthew J S Parker; Alexander Oldroyd; Mark E Roberts; James B Lilleker; Zoe E Betteridge; Neil J McHugh; Ariane L Herrick; Robert G Cooper; Hector Chinoy
Journal:  Rheumatology (Oxford)       Date:  2019-03-01       Impact factor: 7.580

3.  External Validation and Evaluation of Adding MRI or Extended Myositis Antibody Panel to the 2017 EULAR/ACR Myositis Classification Criteria.

Authors:  Queenie Luu; Jessica Day; Alix Hall; Vidya Limaye; Gabor Major
Journal:  ACR Open Rheumatol       Date:  2019-08-08

4.  Clinical Value of 18F-FDG PET/CT Scan and Cytokine Profiles in Secondary Hemophagocytic Lymphohistiocytosis in Idiopathic Inflammatory Myopathy Patients: A Pilot Study.

Authors:  Junyu Liang; Heng Cao; Bowen Wu; Yinuo Liu; Ye He; Bei Xu; Yiduo Sun; Bingjue Ye; Jin Lin
Journal:  Front Immunol       Date:  2021-11-18       Impact factor: 7.561

Review 5.  Current Classification and Management of Inflammatory Myopathies.

Authors:  Jens Schmidt
Journal:  J Neuromuscul Dis       Date:  2018
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.